Clinical Trials Directory

Trials / Completed

CompletedNCT03703037

Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Postterm Pregnancies

Clinical Utility of Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Pregnancies at or Beyond 41 Weeks

Status
Completed
Phase
Study type
Observational
Enrollment
227 (actual)
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Objective: To estimate the value of uterine, fetal cerebral Doppler and oligohydramnios to predict abnormal fetal heart rate tracings in pregnancies at or beyond 41 weeks

Detailed description

This will be a nested case-control study that was conducted at University Hospital Dr. Jose E. Gonzalez after the approval of Institutional ethical committee. Women with low risk late term or postterm pregnancy (at least 41 weeks) with confirm gestational age who will be referred to our Maternal-fetal unit and admitted 1 to 2 days prior to induction of labour according institutional protocol will be recruited and constitute the cohort. Cases will be patients with abnormal intrapartum cardiotocogram (category III fetal heart rate tracing). For each case, four controls will be matched. The primary outcome will be to obtain odds ratios for the Doppler parameters (middle cerebral artery pulsatility index, mean uterine artery pulsatility index and Middle cerebral artery pulsatility index to mean uterine artery pulsatility index ratio) and amniotic fluid index that would be associated with intrapartum category III fetal heart rate tracing.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasound and Doppler ultrasoundAssessment of fetal cerebral and maternal uterine pulsatility index using Doppler ultrasound. Measurement of amniotic fluid index according to four-quadrant technique.

Timeline

Start date
2016-01-01
Primary completion
2019-02-01
Completion
2019-10-01
First posted
2018-10-11
Last updated
2019-10-29

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT03703037. Inclusion in this directory is not an endorsement.